Dinah Knotts

Vice President, Accellacare Site Services

Dinah has been working in the clinical research industry for over 25 years and in her current role is leading the Accellacare Site Network for North America. She started her career working at University Park Research Center as a study coordinator then moving to the CRO side as a CRA and progressing in various study leadership roles.  She moved to Sarah Cannon Research Institute as Director of Clinical Operations working closely with the site network on both sponsor and investigator initiated trials.

Dinah has been at ICON for over 11 years and has held many leadership roles across multiple therapeutic areas including oncology, cardiovascular, rare disease, vaccines, dermatology, CNS and gastrointestinal.  She has over 5 years’ experience leading and overseeing the operational delivery of large Tier 1 partnerships  with the largest having over 75 active studies and achieving over $300 million in new awards.  Dinah lead the operational delivery of the first Pfizer COVID vaccine study with over 48,000 subjects enrolled, receiving Emergency Use Authorization in an unprecedented 247 days and full FDA approval in record time. 

Dinah holds a BA in Mathematics from Purdue University and Post Graduate Diploma in International Business Management, University College of Dublin, Michael Smurfit Graduate Business School.

Michala Worrell

Vice President, EMEA Operations, Accellacare

Michala Worrell is Vice President, Operations, EMEA for Accellacare, ICON’s global site network. Prior to this, Michala worked at ICON for six years as Senior Director managing a team of Project Managers and Directors in Oncology & Cell Therapeutics division in addition to serving as the operations lead for a key strategic client overseeing a large portfolio of trials in various indications. Before joining ICON Michala worked for ten years at AstraZeneca holding a number of project management positions with increasing levels of responsibility and then joined Quintiles where she spent three years as the Oncology Portfolio Lead for a strategic partner. Michala holds a post-graduate certificate in management from Leicester University.

Scott Palmese

Senior Director, Site Network Mobilisation, Accellacare

Scott Palmese is Senior Director, Site Network Mobilisation for Accellacare (part of ICON, plc). In his role, he oversees teams that manage central network functions for ICON's global site network, as well as overall growth and site development strategy.

Prior to his current role, Scott has served in a number of operational and leadership roles at research sites and site networks, including as Vice President of Site Operations for a large, US-based network. He is a specialist in site operations, and has worked in the industry for more than 12 years supporting sites with everything from business development and patient recruitment to financial operations and organisational structure. Through his extensive site experience, Scott has learned how to operate sites effectively and has spent the better part of his career working with sites to help them grow and streamline their operations.